本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ginkgo Bioworks Holdings Inc.

12.26
-0.7400-5.69%
成交量:79.07万
成交额:967.15万
市值:8.26亿
市盈率:-2.47
高:12.82
开:12.69
低:11.70
收:13.00
52周最高:18.22
52周最低:5.37
股本:6,734.03万
流通股本:4,987.32万
量比:0.76
换手率:1.59%
股息:- -
股息率:- -
每股收益(TTM):-4.9625
每股收益(LYR):-5.6397
净资产收益率:-59.94%
总资产收益率:-16.72%
市净率:1.96
市盈率(LYR):-2.17

数据加载中...

2026/10/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities